Induction of labour Flashcards
Discuss elective IOL at term: Cochrane review findings (2020)
-Number of studies included (1)
-What it looked at (2)
-Results (7)
- Includes 34 RCT with IOL for low risk women at or beyond term - 19, 000 women
- Excluded trials where there was an indication for IOL
- Results
-Lower all cause perinatal death RR 0.31
-Need 544 IOL to prevent 1 perinatal death
-Lower still birth rate RR 0.30
-Lower CS rate RR 0.90
-No increase in PPH or perineal trauma, operative vaginal delivery
-Reduced risk of NICU admission and apgars <7 at 5 mins
Discuss membrane sweeping
-Evidence for use (1)
-When to offer (1)
-Advantages
-Disadvantages
- Evidence for use
-Reduces the need for IOL
-NNT 8 to avoid formal IOL
-Increased chance of spontaneous labour
-No difference between SVB or CS
-Data is of low certainty - When to offer
-Offer to all women from 39 weeks to avoid going post dates
-Offer at start of formal IOL - reduces exposure to synto - Advantages
-Shortens IOL to delivery interval
-Reduces Oxy use
-No increased risk of infection - Disadvantages
-Increased maternal pain and bleeding
-Unclear how often to offer
Discuss induction of labour
-Definition
-Incidence
-Outcomes
- Definition
-Artificial initiation of uterine contraction before the onset of spontaneous contractions - Prevalence
-1:4 pregnancies in NZ (rising rate)
-1:5 pregnancies in Australia - Outcomes
-Approximately 15% have instrumental deliveries
-Approximately 22% have CS
What are the indications for IOL (MoH guidelines).
-What conditions should it be offered (8)
-When should it be offered
-What risks are avoided
- Prolonged gestation
-IOL 41-42 weeks
-Lowers risk of: perinatal death, CS, NICU admission, operative VB, lower mec - Term ROM
-IOL within 24hrs
-IOL immediately if GBS + or Mec
-Reduces risk of infection mother and baby, NICU admission, PN abx use, No impact to operative delivery - SGA/IUGR
-IOL at 38 weeks if IUGR but no dopplers available
-IOL at 37 weeks if abnormal UAPI
-IOL at 38 weeks if abnormal MCAPI/CPR or EFW <3rd
-IOL at 40 weeks if normal LV + dopplers and EFW >3rd - Diabetes in pregnancy
-IOL at 40-41 weeks if uncomplicated GDM
-IOL at 38 weeks if fetal macrosomia or other co-morbidities
-IOL at 39 weeks if pre-existing diabetes if no comorbidity
-IOL T1DM on case by case basis - Obstetric cholestasis
-Consider IOL >37 weeks considering bile salts - AMA
-Offer IOL from 39-40 weeks
-Risk of still birth for women >40 double (2:1000)
-Risk of still birth for woman >40 at 39/40 same as woman in 20’s at 41 weeks
-Limited evidence to support IOL - Hypertension
-IOL anytime after 37 weeks for PET
-IOL for chronic HTN but otherwise low risk consider expectant management >37 weeks
-IOL for women with gHTN onset post 37/40 consider IOL to avoid worsening of condition - Multiple pregnancy
-DCDA twins IOL 37-38 weeks
-MCDA twins IOL 36-37 weeks
Discuss indications for IOL:
1. What conditions should IOL not be offered in (5)
2. What conditions is IOL controversial (4)
- Conditions where IOL is not indicated
-ART
-Previous CS
-Previous precipitous labour
-Obesity - higher risk SB but higher IOL failure
-Isolated oligohydramnios - Conditions where IOL is controversial
-Recurrent APH at term
-Reduced FM
-Suspected macrosomia in the absence of diabetes
-Previous still birth
When is IOL contraindicated
-Absolute contra-indications (6)
-Relative contraindications (3)
- Absolute contraindications
-Placenta praevia/ vasa praevia
-Transverse lie
-Active first episode of genital herpes
-Cord prolapse
-Previous classical section
-Maternal or fetal anaomaly that prohibits VB - Relative contraindication
-Triplets or higher order pregnancy
-Breech presentation
-Two or more previous low transverse CS
Discuss risks of IOL (7)
- Uterine hyperstimulation
- Fetal distress - usually due to decreased uterine blood flow
- Failed IOL
- CS if IOL in IUGR preterm (OR 2.7) or PET/HTN preterm
- Cord prolapse
- Uterine rupture
- Increased pain cf spont labour
Discuss failed IOL
-Definitions (2)
-Predictors of failed IOL (4)
-Management options (4)
- Definitions
-Cervix does not change to allow ARM
-12-15hrs of oxytocin without establishing into active labour - Predictors of failed IOL
-Low bishop score
-Maternal weight
-Maternal age
-LLP
-If 10hrs of synto and not in active labour 75%
chance of CS
-If 12 hours of synto and not in active labour chance
of CS 90% - Management options
-Reattempt following day
-Use alternative IOL method
-Await spontaneous labour
-CS
Discuss risk of CS associated with IOL
-When risk of CS is increased (2)
-When risk of CS is decreased (3)
-When risk of CS remains unchanged (5)
- Risk of CS is increased
-Preterm IUGR
-Preterm HTN/PET
2.Risk of CS is decreased
-Post dates
-HTN or mild PET at term
-Maternal request - No change in CS rate
-Diabetes
-Twins
-PPROM/PROM
-IUGR at term
-Macrosomia
Discuss impact of medications used for IOL
-Adverse effects of oxytocin (9)
-Adverse effects of prostaglandins (8)
- Adverse effects of oxytocin
-Fluid retention
-Hyponatremia
-N&V
-Arrythmias
-Anaphylaxis
-Placental abruption
-AFE
-Hyperstimulation
-Uterine rupture - Prostaglandins
-N&V&D
-AFE
-Abruption
-Fetal distress
-Maternal HTN
-Bronchospasm
-Fever
Vaginal discomfort
Discuss risks associated with IOL in women with previous CS (5)
- Increased risk of uterine rupture / dehiscence by 2-3 times
- Increase need for repeat CS compared VBACs who spontaneously labour 1.5 times
- Increased risk of uterine rupture with prostaglandins - 3 times (7.7/1000 to 24.5 / 1000)
- increased risk of uterine rupture with oxytocin 4 times (1:200 to 2:100)
- Risk of induction with balloon - lower chance of uterine rupture
Discuss bishops score
-What does the bishop score comprise of
-Significance of a score >=9
-Significance of a score >=8
-Significance of a score <6
- Composition of Bishops score
-Score with 0,1 or 2
-Cervical dilatation <1, 1-2, 3-4
-Length of cervix >2, 1-2, <1
-Station of PP -3, -2, -1
-Consistency - firm medium soft
-Position - posterior, central, anterior - Significance of BS>=9
-Chance of VB same as spont labour - Significance of BS >=8
-Chance of failed IOL 3% - Significance of score <6
-Cervical ripening required
Discuss prostaglandins for cervical ripening
-Mode of action (1)
-Justification for use in IOL (1)
-Types (5)
-Time between different prostaglandin commencement of oxy (3)
- Mode of action
-Softens cervix and brings on uterine contractions - Justification of use
-Use in women with unfavourable cervix improves chance of VB within 24hrs compared to oxy alone - Types
Prostaglandin E2 - dinoprostone
-Prostin Gel 1 or 2 mg every 6hrs
-Cervadil pessary 10mg for 24hrs
-Tablet 3mg PV every 6-8hrs
Prostaglandin E1 - Misoprostol
-PV or PO 25mcg Q2H - Time between prostaglandin and oxy
-Prostin gel - 6hrs
-Cervadil - 30mins
-Misoprostol - 4hrs
Compare outcomes between using cervadil and prostin gel (5)
- Similar rates of VB within 24hrs
-No difference in CS rates
-No difference in hyperstimulation with FHR changes - overall rate 5%
-Cervidil associated with less instrumental deliveries
-Cervidil associated with less rates of cervix remaining unfavourable
Discuss outcomes of PV misoprostol compared to PGE2 PV (6)
-Higher chance of VB within 24hrs with miso
-Less need for oxytocin augmentation with miso
-Less use of epidural with miso
-No difference in uterine hyperstimulation between the two
-No difference in CS rates
-Higher mec stained liquor with miso
Discuss outcomes for PO miso vs PV misoprostol (6)
-Similar rates of VB within 24hrs
-Similar CS rates
-Less hyperstimulation with PO miso
-Less PPH with PO miso
-Less low 5 mins apgar scores with PO miso
-Higher mec with PO miso
Discuss outcomes for PO miso vs PV PGE2 (1)
- Lower CS rates in PO miso RR 0.88
-Overall CS rate for PO miso 15%
Discuss contraindications for use of misoprostol (6)
-PTL
-Multiple pregnancy
-Previous CS or uterine surgery
-IUGR with abnormal dopplers or EFW <5%
-Suspicion of fetal compromise including abnormal CTG
-Maternal conditions - severe asthma, cardiovascular conditions
Discuss mechanical ripening of the cervix for IOL
-Mechanism (2)
-Contraindications (1)
-Method (3)
-Advantages (2)
-Disadvantages (5)
- Mechanism
-Direct physical pressure on internal os
-Increase release of prostaglandins from decidua, adjacent membranes, cervix - Contra-indications
-Low lying placenta - Method
-Single or double balloon passed transcervically for 12-24hrs
-Inflation of balloon >30mL associated with higher rate of birth within 24hrs compared to low inflation
-Little difference in outcomes with single or double balloon - Advantages
-Lower cost
-Reduced side effects - Disadvantages
-Difficulty with insertion
-Discomfort for woman
-Risk of infection
-Fetal malposition once balloon removed
-Urinary retention
Compare outcomes between balloon catheter IOL and PGE2 (dinoprost) - Most useful (7 points)
-No difference in CS
-No difference in assisted VB
-No difference in birth not achieved within 24hrs
-Balloon associated with more need for oxytocin
-Balloon associated with less uterine hyperstimulation
-Balloon associated with less neonatal morbidity RR 0.48
-Balloon associated with reduced risk of NICU
Compare outcomes between balloon catheter and PO misoprostol
-Balloon associated with increased risk of NO VB within 24hrs
-Balloon associated with increased CS rate (Also true if comparing with PV miso)
Discuss ARM for IOL
-Indications (3)
-Timing of AMR in IOL process
-Comparison of ARM alone vs ARM + oxytocin
- Indications
-To augment labour
-To permit FSE
-To permit FBS - Timing of ARM
-No clear consensus
-Early ARM before 3-4cm dilated associated with reduced time until delivery
-Early ARM may increase risk of CS + chorio but evidence is conflicting. Some studies say reduced.
-Can be done prior to or after oxytocin started. Consider starting oxytocin if head high or cervix unfavourable - Comparison of ARM alone vs ARM + oxy
-More VB within 24hrs if ARM + oxy. RR
-Fewer instrumental deliveries if ARM + oxy
-No difference in CS rates, PPH, fever
-Poor maternal satisfaction with oxy cf prostaglandin (RR 53)
Discuss oxytocin use for IOL
-Types of protocol (1)
-Evidence around use (6)
- Can have low dose and high dose protocols
- Evidence around use
-MOH support DHBs designing own protocol
-No evidence for different protocols for multips and nulips
-No evidence for different protocols for augmentation vs IOL
-Limited evidence supports high dose oxy for shorted IOL time until delivery
-No evidence for maximum dose in women with CS
-Oxy started immediately post ARM associated with increased VB within 12 hrs, decreased maternal pyrexia, increased maternal satisfaction, increased active labour within 4 hrs
Discuss prolonged pregnancy
-Incidence (2)
-Aetiology (3)
-Risk factors (6)
-Maternal risks (5)
- Incidence
-10-25% (Nice 17%)
-Can be reduced with correct EDD - Aetiology
-Majority unknown cause
-Anencephaly - where absence of fetal hypothalamus
-Defects in fetal production of hormones related to parturition - Risk factors
-Personal or family Hx
-Nulliparity
-Male fetus
-Obesity
-AMA
-Ethnicity - more common in Caucasian women - Maternal risks
-Increased instrumental delivery
-Increased dysfunctional labour
-Increased risk PPH
-Increased obstetric trauma
-Increased shoulder dystocia
-Increased CS delivery
-Increased NICU admission
-Increase risk SB